Transient erythroblastopenia of childhood. Prospective study of fifty patients

I Cherrick1, G Karayalcin, P Lanzkowsky

  • 1Schneider Children's Hospital of Long Island Jewish Medical Center, New Hyde Park, NY 11042.

The American Journal of Pediatric Hematology/Oncology
|November 1, 1994
PubMed

Insights

Transient erythroblastopenia of childhood (TEC) often involves neutropenia, which resolves independently of anemia recovery. This study clarifies TEC diagnosis, especially differentiating it from hemolytic conditions.

Area of Science:

  • Pediatric Hematology
  • Clinical Research
  • Hematological Disorders

Background:

  • Transient erythroblastopenia of childhood (TEC) is a common pediatric hematological disorder.
  • Understanding TEC's clinical course and associations is crucial for accurate diagnosis and management.
  • Distinguishing TEC from other conditions, such as hemolytic anemia, is clinically important.

Purpose of the Study:

  • To prospectively evaluate 50 patients with transient erythroblastopenia of childhood (TEC).
  • To compare patients presenting with reticulocytopenia (group I) versus those in recovery with reticulocytosis (group II).
  • To describe the clinical course, particularly neutrophil involvement, and review literature on TEC.

Main Methods:

  • Prospective evaluation of 50 pediatric patients diagnosed with TEC between 1983 and 1991.
  • Patients were categorized into two groups: reticulocytopenic (group I) and reticulocytotic (group II).
  • All patients were followed until complete recovery.

Main Results:

  • 36 patients were in group I (reticulocytopenic) and 14 in group II (reticulocytotic).
  • Neutropenia occurred in 64% of patients across both groups.
  • Neutropenia resolution varied, with lowest absolute neutrophil counts (ANC) occurring before, simultaneous with, or after peak reticulocyte counts.

Conclusions:

  • Neutropenia is an integral component of TEC, with its recovery independent of anemia resolution.
  • This study provides a detailed description of patients in the recovery phase, aiding diagnosis and differentiation from hemolytic processes.
  • Certain previously reported associations with TEC were not supported by this large patient cohort.
Abstract